D 473
Alternative Names: D-473Latest Information Update: 28 Sep 2023
At a glance
- Originator Wayne State University
- Developer Tonix Pharmaceuticals Holding Corp
- Class Antidepressants; Pyrans; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Depressive disorders
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for preclinical development in Depressive disorders in USA (PO)
- 20 Aug 2019 Tonix Pharmaceuticals Holding Corp in-licenses TNX 1600 and other pyran-based compounds and related patents from Wayne State University and TRImaran Pharma
- 06 Feb 2014 Wayne State University has patents pending for pyran-based compounds in USA